SanBio Company Limited (TYO:4592)
2,237.00
-18.00 (-0.80%)
May 12, 2026, 3:30 PM JST
SanBio Company Market Cap
SanBio Company has a market cap or net worth of 175.05 billion as of May 12, 2026. Its market cap has increased by 45.20% in one year.
Market Cap
175.05B
Enterprise Value
161.20B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,237.00
Market Cap Chart
Since April 8, 2015, SanBio Company's market cap has increased from 77.34B to 175.05B, an increase of 126.34%. That is a compound annual growth rate of 7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 175.98B | 33.45% |
| Dec 30, 2025 | 131.88B | 147.58% |
| Dec 30, 2024 | 53.27B | 15.83% |
| Dec 29, 2023 | 45.99B | -5.12% |
| Dec 30, 2022 | 48.47B | -7.07% |
| Dec 30, 2021 | 52.16B | -24.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 166.37B |
| PeptiDream | 144.78B |
| Takara Bio | 137.51B |
| Nxera Pharma | 111.18B |
| Oncolys BioPharma | 83.70B |
| Cuorips | 52.27B |
| Healios K.K. | 44.96B |
| Japan Tissue Engineering | 25.10B |